Bradley Saenger

Insider Reports History

Entity
Individual
Location
C/O Tonix Pharmaceuticals Holding Corp, 509 Madison Ave., Suite 306, New York, NY
Signature
/s/ Bradley Saenger
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Bradley Saenger:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Tonix Pharmaceuticals Holding Corp. Chief Financial Officer Stock Option 282K Feb 27, 2024 Direct

Insider Reports Filed by Bradley Saenger

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TNXP Tonix Pharmaceuticals Holding Corp. Feb 27, 2024 2 $0 4 Feb 29, 2024 Chief Financial Officer
TNXP Tonix Pharmaceuticals Holding Corp. Feb 23, 2023 2 $0 4 Feb 24, 2023 Chief Financial Officer
TNXP Tonix Pharmaceuticals Holding Corp. Feb 15, 2022 4 $0 4 Feb 17, 2022 Chief Financial Officer
TNXP Tonix Pharmaceuticals Holding Corp. Dec 31, 2021 1 $10.6K 5 Feb 11, 2022 Chief Financial Officer